Gritstone Oncology to Present at Two Upcoming Investor Conferences in June
June 04 2020 - 8:00AM
Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology
company developing the next generation of cancer immunotherapies to
fight multiple cancer types, today announced that Andrew Allen,
M.D., Ph.D., co-founder, president and chief executive officer,
will present a company overview at two upcoming investor
conferences in June.
- Goldman Sachs 41st Annual Global Healthcare Conference on
Wednesday, June 10, 2020 at 2:10 p.m. ET
- Raymond James Human Health Innovation Conference on Thursday,
June 18, 2020 at 1:00 p.m. ET
A live webcast will be available within the Investors &
Media section of the Gritstone Oncology website at
https://ir.gritstoneoncology.com/investors/events. An archived
replay will be accessible for 30 days following the event.
About Gritstone Oncology Gritstone Oncology
(Nasdaq: GRTS), a clinical-stage biotechnology company, is
developing the next generation of cancer immunotherapies to fight
multiple cancer types. Gritstone develops its products by
leveraging two key pillars—first, a proprietary machine
learning-based platform, Gritstone EDGETM, which is designed to
predict, from a routine tumor biopsy, the tumor-specific
neoantigens (TSNA) that are presented on a patient’s tumor cells;
and second, the ability to develop and manufacture potent
immunotherapies utilizing patients’ TSNA to potentially drive the
patient’s immune system to specifically attack and destroy tumors.
The company’s “off the shelf” shared neoantigen-based
immunotherapy, SLATE, and its individualized neoantigen-based
immunotherapy, GRANITE, are being evaluated in Phase 1 clinical
studies. Novel tumor-specific antigens can also provide targets for
bispecific antibody (BiSAb) therapeutics for solid tumors, and
Gritstone’s BiSAb program is currently in lead optimization. For
more information, please visit gritstoneoncology.com.
Contacts Media: Dan Budwick 1AB (973) 271-6085
dan@1abmedia.com
Investors: Alexandra Santos Wheelhouse Life Science Advisors
(510) 871-6161 asantos@wheelhouselsa.com
Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
From Sep 2023 to Sep 2024